Suitors up price for Bavarian Nordic
Two private equity firms bidding for Bavarian Nordic have increased their offer for the Danish maker of vaccines for mpox, cholera and chikungunya, after shareholders…
Chikungunya
Bavarian Nordic’s troubled takeover bid gets EU clearance
The European Commission has approved a private equity takeover bid for Bavarian Nordic, the Danish maker of vaccines for mpox, cholera and chikungunya, leaving disgruntled…
Valneva extends loans after chikungunya jab concerns
Vaccine specialist Valneva has refinanced its debt and cut its revenue forecast for this year after the US FDA suspended the licence for its chikungunya…
Chikungunya to spread beyond tropical regions, machine learning predicts
A new model which uses machine learning to forecast the spread of chikungunya has predicted that the mosquito-borne virus will spread much further than expected,…